Status:
UNKNOWN
Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss
Lead Sponsor:
Sheba Medical Center
Conditions:
Sudden Loss of Hearing
Eligibility:
All Genders
16+ years
Phase:
PHASE2
PHASE3
Brief Summary
sudden sensorineural hearing loss: * idiopathic in most cases * 5-20/100,000 new cases annually in the U.S * no establishes pathogenesis * treated with oral steroids in most cases * \~50% improvement...
Eligibility Criteria
Inclusion
- patients with sudden sensorineural hearing loss
Exclusion
- age less than 16 years
- contraindication for oral steroid treatment
- prior steroid treatment for hearing loss
- pregnent women
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
End Date :
December 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00416143
Start Date
June 1 2006
End Date
December 1 2008
Last Update
December 27 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Tel Litwinsky, Israel